you are here: Home News Pharmaceutical Sector

Pharmaceutical Sector

Abbott India posts 15% rise in Q2 profit on strong demand, price hikes
Aurobindo Pharma now weighs mega IPO of Eugia Pharma Specialities to raise around Rs 4,500 crore
IndiaRF to acquire API, CRAMS business of Ind-Swift Laboratories for Rs 1,650 crore
Lupin gets USFDA nod for birth-control pill
Is the pharma sector on the road to regaining its mojo?
Pharma Q4 preview: US launches, steady domestic growth to drive recovery
Are pharma cos poised for a bull ride? Here's what analysts believe
Natco Pharma proposes to buy back 1.64% stake for Rs 210 crore
Wockhardt shuts manufacturing unit in US to cut down on costs
PharmEasy to acquire 66.1% stake in Thyrocare for Rs 4,546 crore
5 reasons why pharma stocks could still come under pressure
Here is a wrap on US-FDA woes for Indian pharmaceutical sector
Budget 2017: Govt to frame new rules on medical devices to draw investments
India rejects 955 pharma patent applications in last 3 years
India needs to incorporate changes in pharma sector: WHO RD
Pharma exports growth heading for a sharp decline: Crisil
US and EU regulators urge Indian drug cos to step up standards
CCI extends deadline for bids to conduct pharma study
India interested in reviving FTA talks with EU: Sitharam
Comm Min may set up think-tank for pharmaceutical sector
Pharma, food biz to benefit company by year end: Snowman
Interact with CNBC-TV18: Pharma sector doing well, will continue to do so: Hiren Ved
Eyeing overseas listing; moved biz to S'pore arm: Jubilant
FIPB may defer FDI in pharma sector
EU fines Ranbaxy, others for blocking cheaper drugs

English

Markets

News

Personal Finance

Mutual Funds

Commodities

Media

Invest Now

Specials

Pharmaceutical Sector

Abbott India posts 15% rise in Q2 profit on strong demand, price hikes

Aurobindo Pharma now weighs mega IPO of Eugia Pharma Specialities to raise around Rs 4,500 crore

IndiaRF to acquire API, CRAMS business of Ind-Swift Laboratories for Rs 1,650 crore

Lupin gets USFDA nod for birth-control pill

Is the pharma sector on the road to regaining its mojo?

Pharma Q4 preview: US launches, steady domestic growth to drive recovery

Are pharma cos poised for a bull ride? Here's what analysts believe

Natco Pharma proposes to buy back 1.64% stake for Rs 210 crore

Wockhardt shuts manufacturing unit in US to cut down on costs

PharmEasy to acquire 66.1% stake in Thyrocare for Rs 4,546 crore

5 reasons why pharma stocks could still come under pressure

Here is a wrap on US-FDA woes for Indian pharmaceutical sector

Budget 2017: Govt to frame new rules on medical devices to draw investments

India rejects 955 pharma patent applications in last 3 years

India needs to incorporate changes in pharma sector: WHO RD

Pharma exports growth heading for a sharp decline: Crisil

US and EU regulators urge Indian drug cos to step up standards

CCI extends deadline for bids to conduct pharma study

India interested in reviving FTA talks with EU: Sitharam

Comm Min may set up think-tank for pharmaceutical sector

Pharma, food biz to benefit company by year end: Snowman

Interact with CNBC-TV18: Pharma sector doing well, will continue to do so: Hiren Ved

Eyeing overseas listing; moved biz to S'pore arm: Jubilant

FIPB may defer FDI in pharma sector

EU fines Ranbaxy, others for blocking cheaper drugs